5-lipoxygenase inhibitors (NCI)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Name5-lipoxygenase inhibitors (NCI)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionArachidonate 5-lipoxygenase inhibitorsPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ inhibitors

TargetsPeroxisome proliferator-activated receptor γArachidonate 5-lipoxygenasePeroxisome proliferator-activated receptor α

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNational Cancer Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institutes Of Health National Cancer Institute

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A